Adverum Biotechnologies
ADVM
ADVM
69 hedge funds and large institutions have $74.1M invested in Adverum Biotechnologies in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less call options, than puts
Call options by funds: $45K | Put options by funds: $62K
38% less capital invested
Capital invested by funds: $120M → $74.1M (-$46M)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
69
Holding in Top 10
4
Calls
$45K
Puts
$62K
Top Buyers
| 1 | +$586K | |
| 2 | +$487K | |
| 3 | +$432K | |
| 4 |
Goldman Sachs
New York
|
+$358K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$281K |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$5.85M | |
| 3 | -$2.92M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$989K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$826K |